CONCLUSION
This case demonstrates that minimally invasive mitral valve repair can
be safely performed in patients with hemophilia. Using a comprehensive
approach, including a FVIII level-controlled replacement therapy, a
minimally invasive valve repair, and sinus rhythm restoration, allows to
minimize the risk of complications in the perioperative and
postoperative periods in patients with severe hemophilia A.